EUVIMEDEUVIMED entdecken
Crossref

Newborn screening for biliary atresia using direct bilirubin: An implementation science study

Tebyan Rabbani iD, Jay Shah

Journal of Medical Screening · 2025

DOI: 10.1177/09691413241284243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Screening, 2025. Verfasst von Tebyan Rabbani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, CA, USA. Hauptthemen laut MEDLINE: Biliary Atresia, Neonatal Screening, Bilirubin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Biliary atresia (BA) is a liver disease of infancy characterized by obstruction of the biliary tree. Infants with BA have the best outcomes when identified early and the Kasai portoenterostomy is performed before 45 days of life (DoL). In our hospital system, the average age at Kasai was 60 DoL. To address the problem of late presentation, we implemented a two-stage BA screening strategy utilizing direct bilirubin (DB).

Methods

New institutional policies were established that all newborns were tested at 24–48 h of life, and those with levels ≥0.5 mg/dL were followed further. The infant's primary care provider was contacted to recommend a repeat DB at 2 weeks of life. If the repeat DB was ≥1.0 mg/dL, the patient was evaluated by gastroenterology.

Results

Over the 16 months, 3880 infants were born and 3861 (99.5%) were screened; 53 infants (1.3%) had DB levels ≥0.5 mg/dL initially. Upon repeat testing at 2 weeks, there were three groups of infants: not retested ( n = 1), retested

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary AtresiaNeonatal ScreeningBilirubinHumansInfant, NewbornFemaleMaleImplementation Science

Stichwörter der Autor:innen

Biliary atresiaKasaidirect bilirubinportoenterostomyscreening

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, CA, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, UT Health San Antonio, San Antonio, TX, USA.

ORCID-Profile: Tebyan Rabbani

Zitieren

APA

Rabbani, T., & Shah, J. (2025). Newborn screening for biliary atresia using direct bilirubin: An implementation science study. Journal of Medical Screening. https://doi.org/10.1177/09691413241284243

Vancouver

Rabbani T, Shah J. Newborn screening for biliary atresia using direct bilirubin: An implementation science study. Journal of Medical Screening. 2025. doi:10.1177/09691413241284243

BibTeX
@article{Rabbani2025,
  author = {Rabbani, Tebyan and Shah, Jay},
  title = {Newborn screening for biliary atresia using direct bilirubin: An implementation science study},
  journal = {Journal of Medical Screening},
  year = {2025},
  doi = {10.1177/09691413241284243}
}
Kostenlos starten →